Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Clinical trial NCT02510794 · COMPLETED
Trial details
- NCT number
- NCT02510794
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-28
- Primary completion
- 2018-04-10
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.